Anne Seidlitz studied pharmacy in Greifswald and obtained her license as a pharmacist in 2003. From 2003 to 2005, she worked as a team member and later on team leader in the galenics department of the Arzneimittel Werke Altona AG in Hamburg. Afterwards, she returned to Greifswald University and received a Doctor of Natural Sciences in Pharmaceutical Technology in 2009. In 2015, she was granted the degree of a habilitated Doctor in the Natural Sciences. Furthermore, she was the qualified person according to the German Medicinal Products Act at the hospital pharmacy of the University Medicine Greifswald. After positions as substitute professor at the University of Hamburg and the Friedrich Schiller University Jena she was appointed full professor of Pharmaceutics and Biopharmaceutics at the Heinrich Heine University Düsseldorf in 2021. Anne Seidlitz has accepted the appointment by the Freie Universität Berlin for the full professorship in pharmaceutical technology starting in October 2024. Her main research areas are dosage form development with a focus on solid dosage forms and biorelevant dissolution testing of parenteral non-oral dosage forms. She is an active participant in different pharmaceutical organisations such as the International Association for Pharmaceutical Technology (Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik, APV), the EUFEPS Network On Bioavailability And Biopharmaceutics and the scientific council of the German Federal Chamber of Pharmacists (Bundesapothekerkammer).

Current research areas of the Seidlitz group

For more information on our current research, please visit the Research section of our website.